Showing results (311-320 of 345) with videos related to
Sort By:
Pageof 35
American Journal of Physiology. Endocrinology and Metabolism|March 17, 2005
Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cellsJoost van der Hoek, Marlijn Waaijers, Peter M van Koetsveld, et al.The Journal of Clinical Endocrinology and Metabolism|November 20, 2008
Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studiesM van Hoek, L J Hofland, Y B de Rijke, et al.Journal of Neuroendocrinology|June 24, 2026
Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS databaseDetlef K Bartsch, L Mais, L de Mestier, et al.Neuroendocrinology|February 3, 2016
Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor CellsRoxanne C S van Adrichem, Wouter W de Herder, Kimberly Kamp, et al.AACE Clinical Case Reports|May 23, 2022
Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor-Interacting Protein-mutated Pediatric SomatotropinomaSelveta Sanne van Santen, Adrian F Daly, Michael Buchfelder, et al.European Journal of Endocrinology|July 27, 2022
Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation studyClaudia Campana, Peter M van Koetsveld, Richard A Feelders, et al.The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dopamine receptor expression and function in human normal adrenal gland and adrenal tumorsRosario Pivonello, Diego Ferone, Wouter W de Herder, et al.Annals of Surgery|August 2, 2007
Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptorsGiovanni Vitale, Casper H J van Eijck, Peter M van Koetsveld Ing, et al.The Journal of Clinical Endocrinology and Metabolism|October 2, 2013
Preoperative normalization of cortisol levels in Cushing's disease after medical treatment: consequences for somatostatin and dopamine receptor subtype expression and in vitro response to somatostatin analogs and dopamine agonistsR van der Pas, R A Feelders, F Gatto, et al.The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitroRichard A Feelders, Steven W J Lamberts, Leo J Hofland, et al.Pageof 35